Publication | Open Access
Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma
26
Citations
0
References
2018
Year
Surgical OncologyContinuous Intravenous InfusionGastrointestinal OncologyMedicineGastroenterologySurgeryCancer TreatmentOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!